New Alzheimer’s Treatment Using Donanemab Begins in Milan The IRCCS Policlinico San Donato in Milan has initiated a novel Alzheimer’s treatment using donanemab, a monoclonal antibody targeting beta-amyloid plaques, according …
Tag: